

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.08984834 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.80465486 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.80465486 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.44938693 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.26047973 |
| 6 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.96952218 |
| 7 | positive regulation of B cell differentiation (GO:0045579) | 4.66060905 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.57044247 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.51381140 |
| 10 | negative regulation of cell killing (GO:0031342) | 4.51381140 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.43148362 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 4.34223482 |
| 13 | positive regulation by symbiont of host defense response (GO:0052509) | 4.21041670 |
| 14 | modulation by symbiont of host defense response (GO:0052031) | 4.21041670 |
| 15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.21041670 |
| 16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.21041670 |
| 17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.21041670 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 4.21041670 |
| 19 | B cell receptor signaling pathway (GO:0050853) | 4.19901341 |
| 20 | regulation of B cell differentiation (GO:0045577) | 4.17202321 |
| 21 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.08421628 |
| 22 | detection of other organism (GO:0098543) | 4.08205706 |
| 23 | detection of bacterium (GO:0016045) | 3.90794148 |
| 24 | immunoglobulin mediated immune response (GO:0016064) | 3.88478367 |
| 25 | leukocyte aggregation (GO:0070486) | 3.88222050 |
| 26 | positive thymic T cell selection (GO:0045059) | 3.84426563 |
| 27 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.83964277 |
| 28 | microglial cell activation (GO:0001774) | 3.76205181 |
| 29 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.62785789 |
| 30 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.61985050 |
| 31 | negative regulation of phagocytosis (GO:0050765) | 3.58962681 |
| 32 | detection of external biotic stimulus (GO:0098581) | 3.56152123 |
| 33 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.56043639 |
| 34 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.54026935 |
| 35 | negative regulation of T cell mediated immunity (GO:0002710) | 3.53727309 |
| 36 | detection of molecule of bacterial origin (GO:0032490) | 3.53560505 |
| 37 | respiratory burst (GO:0045730) | 3.50862632 |
| 38 | neutrophil activation involved in immune response (GO:0002283) | 3.49381519 |
| 39 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.48822832 |
| 40 | negative T cell selection (GO:0043383) | 3.48220922 |
| 41 | regulation of mast cell degranulation (GO:0043304) | 3.48196574 |
| 42 | T-helper 1 type immune response (GO:0042088) | 3.48184895 |
| 43 | negative thymic T cell selection (GO:0045060) | 3.45990692 |
| 44 | macrophage activation (GO:0042116) | 3.44820142 |
| 45 | positive regulation of interferon-alpha production (GO:0032727) | 3.43752357 |
| 46 | mast cell activation (GO:0045576) | 3.43157496 |
| 47 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.39830942 |
| 48 | positive regulation of mast cell activation (GO:0033005) | 3.34820650 |
| 49 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.33216064 |
| 50 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.32587547 |
| 51 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.29471443 |
| 52 | macrophage activation involved in immune response (GO:0002281) | 3.29150626 |
| 53 | regulation of interferon-alpha production (GO:0032647) | 3.28768264 |
| 54 | T cell migration (GO:0072678) | 3.28059276 |
| 55 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.24497295 |
| 56 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.20794354 |
| 57 | defense response to protozoan (GO:0042832) | 3.19170315 |
| 58 | response to peptidoglycan (GO:0032494) | 3.17727622 |
| 59 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.17480687 |
| 60 | positive regulation of antigen processing and presentation (GO:0002579) | 3.17378368 |
| 61 | response to interleukin-15 (GO:0070672) | 3.17261968 |
| 62 | tolerance induction (GO:0002507) | 3.16519931 |
| 63 | B cell mediated immunity (GO:0019724) | 3.16196732 |
| 64 | T cell homeostasis (GO:0043029) | 3.15081404 |
| 65 | detection of biotic stimulus (GO:0009595) | 3.14761756 |
| 66 | regulation of mast cell activation (GO:0033003) | 3.13895251 |
| 67 | myeloid cell activation involved in immune response (GO:0002275) | 3.13312855 |
| 68 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.11798123 |
| 69 | cellular extravasation (GO:0045123) | 3.10798616 |
| 70 | myeloid dendritic cell activation (GO:0001773) | 3.10754126 |
| 71 | regulation of T cell tolerance induction (GO:0002664) | 3.09955376 |
| 72 | interferon-gamma production (GO:0032609) | 3.08891461 |
| 73 | response to protozoan (GO:0001562) | 3.08593167 |
| 74 | response to muramyl dipeptide (GO:0032495) | 3.06346777 |
| 75 | mature B cell differentiation (GO:0002335) | 3.06183227 |
| 76 | positive T cell selection (GO:0043368) | 3.05960629 |
| 77 | regulation of leukocyte degranulation (GO:0043300) | 3.05384992 |
| 78 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.05030594 |
| 79 | positive regulation of mast cell degranulation (GO:0043306) | 3.05030594 |
| 80 | ribosomal small subunit assembly (GO:0000028) | 3.02724582 |
| 81 | response to type I interferon (GO:0034340) | 3.02114421 |
| 82 | regulation of tolerance induction (GO:0002643) | 3.01740372 |
| 83 | NIK/NF-kappaB signaling (GO:0038061) | 2.99330993 |
| 84 | type I interferon signaling pathway (GO:0060337) | 2.99286075 |
| 85 | cellular response to type I interferon (GO:0071357) | 2.99286075 |
| 86 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.99031589 |
| 87 | lymphocyte homeostasis (GO:0002260) | 2.95807972 |
| 88 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.95775089 |
| 89 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.95719041 |
| 90 | thymic T cell selection (GO:0045061) | 2.95278600 |
| 91 | pinocytosis (GO:0006907) | 2.94604791 |
| 92 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.94146955 |
| 93 | negative regulation of interleukin-12 production (GO:0032695) | 2.92077039 |
| 94 | neutrophil activation (GO:0042119) | 2.89940608 |
| 95 | B cell homeostasis (GO:0001782) | 2.89730757 |
| 96 | negative regulation of innate immune response (GO:0045824) | 2.88845573 |
| 97 | neutrophil mediated immunity (GO:0002446) | 2.87875414 |
| 98 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.86999063 |
| 99 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.86999063 |
| 100 | myeloid leukocyte activation (GO:0002274) | 2.86628343 |
| 101 | negative regulation of interleukin-6 production (GO:0032715) | 2.85644523 |
| 102 | T cell selection (GO:0045058) | 2.82158214 |
| 103 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.82050664 |
| 104 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.81654292 |
| 105 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.80642587 |
| 106 | mast cell degranulation (GO:0043303) | 2.80442487 |
| 107 | mast cell activation involved in immune response (GO:0002279) | 2.80442487 |
| 108 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.79492118 |
| 109 | leukocyte cell-cell adhesion (GO:0007159) | 2.78632633 |
| 110 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.78176947 |
| 111 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.77861238 |
| 112 | response to host immune response (GO:0052572) | 2.77861238 |
| 113 | cellular response to zinc ion (GO:0071294) | 2.76990590 |
| 114 | myeloid dendritic cell differentiation (GO:0043011) | 2.76772471 |
| 115 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.75923504 |
| 116 | cellular response to interleukin-15 (GO:0071350) | 2.73945114 |
| 117 | germinal center formation (GO:0002467) | 2.73846587 |
| 118 | actin nucleation (GO:0045010) | 2.73289906 |
| 119 | mature B cell differentiation involved in immune response (GO:0002313) | 2.71321501 |
| 120 | granulocyte activation (GO:0036230) | 2.70036100 |
| 121 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.69239557 |
| 122 | response to host (GO:0075136) | 2.69239557 |
| 123 | response to host defenses (GO:0052200) | 2.69239557 |
| 124 | positive regulation of granulocyte differentiation (GO:0030854) | 2.68170827 |
| 125 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.68099009 |
| 126 | leukocyte homeostasis (GO:0001776) | 2.67803799 |
| 127 | regulation of antigen processing and presentation (GO:0002577) | 2.67755775 |
| 128 | positive regulation of isotype switching (GO:0045830) | 2.67699419 |
| 129 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.62822048 |
| 130 | negative regulation of granulocyte differentiation (GO:0030853) | 2.61796837 |
| 131 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.61626307 |
| 132 | leukocyte degranulation (GO:0043299) | 2.61026325 |
| 133 | negative regulation of B cell proliferation (GO:0030889) | 2.60351457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.20902355 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.46621301 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.85403579 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.68111510 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.51833373 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.49816430 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.41589170 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 3.07235945 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.97494384 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.88955280 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.80668437 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.80365093 |
| 13 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.79761625 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.77267169 |
| 15 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.70804118 |
| 16 | * EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.68505547 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.61511150 |
| 18 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.58664269 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.43638495 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.42358000 |
| 21 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.41033080 |
| 22 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.40902750 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.38457384 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.35588577 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.26889070 |
| 26 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.19698996 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.16806700 |
| 28 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.13519204 |
| 29 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.13169971 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 2.12930066 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12599872 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.10275125 |
| 33 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04132042 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.03085545 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 2.01952745 |
| 36 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.01127733 |
| 37 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.00215881 |
| 38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.96677935 |
| 39 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.90244266 |
| 40 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89178946 |
| 41 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.81301487 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.78509773 |
| 43 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76462762 |
| 44 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.74320028 |
| 45 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70780205 |
| 46 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.69833391 |
| 47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.68571223 |
| 48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.64157957 |
| 49 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.64004008 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.59168296 |
| 51 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.52950955 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.51585194 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.46986282 |
| 54 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.44217023 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.43117019 |
| 56 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.42580450 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.42125235 |
| 58 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.41855969 |
| 59 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41444105 |
| 60 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.36064868 |
| 61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35400551 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30363750 |
| 63 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.28353161 |
| 64 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.27577562 |
| 65 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27069990 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.26756060 |
| 67 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26519763 |
| 68 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25938566 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25849505 |
| 70 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25818330 |
| 71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25293928 |
| 72 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.22794991 |
| 73 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22474180 |
| 74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19021203 |
| 75 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.18160579 |
| 76 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17913637 |
| 77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17727677 |
| 78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.17181914 |
| 79 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16972308 |
| 80 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.13934633 |
| 81 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13928956 |
| 82 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13922936 |
| 83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13613774 |
| 84 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12770720 |
| 85 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11748488 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09755762 |
| 87 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07757531 |
| 88 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06916617 |
| 89 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04788328 |
| 90 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.04684953 |
| 91 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04177342 |
| 92 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.03449870 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03120148 |
| 94 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03032286 |
| 95 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.00639288 |
| 96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00396524 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99793945 |
| 98 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99051610 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98440187 |
| 100 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98438929 |
| 101 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.98012987 |
| 102 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97742211 |
| 103 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.96223410 |
| 104 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93995628 |
| 105 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92124638 |
| 106 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.90553137 |
| 107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89927090 |
| 108 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.89908106 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89690884 |
| 110 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.88639833 |
| 111 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85885607 |
| 112 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.85024315 |
| 113 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83415576 |
| 114 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.82981377 |
| 115 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82626371 |
| 116 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.81341511 |
| 117 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81282505 |
| 118 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.79416502 |
| 119 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.78876396 |
| 120 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.78573171 |
| 121 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78445848 |
| 122 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.78335144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.27362633 |
| 2 | MP0005671_abnormal_response_to | 3.28572581 |
| 3 | MP0000685_abnormal_immune_system | 3.11786333 |
| 4 | * MP0001800_abnormal_humoral_immune | 3.07932013 |
| 5 | MP0003436_decreased_susceptibility_to | 3.02782265 |
| 6 | MP0003303_peritoneal_inflammation | 2.97753817 |
| 7 | MP0009785_altered_susceptibility_to | 2.88429172 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.87424789 |
| 9 | MP0001790_abnormal_immune_system | 2.86228558 |
| 10 | MP0005387_immune_system_phenotype | 2.86228558 |
| 11 | * MP0002452_abnormal_antigen_presenting | 2.80161281 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.79804116 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.73160213 |
| 14 | * MP0002723_abnormal_immune_serum | 2.67860416 |
| 15 | * MP0002420_abnormal_adaptive_immunity | 2.64314291 |
| 16 | * MP0005025_abnormal_response_to | 2.62524772 |
| 17 | * MP0001819_abnormal_immune_cell | 2.62159012 |
| 18 | * MP0002419_abnormal_innate_immunity | 2.62034216 |
| 19 | * MP0002398_abnormal_bone_marrow | 2.47757916 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.47539783 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.34939279 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.28205196 |
| 23 | MP0006082_CNS_inflammation | 2.27247738 |
| 24 | * MP0000716_abnormal_immune_system | 2.23994588 |
| 25 | MP0002405_respiratory_system_inflammati | 2.19134259 |
| 26 | * MP0000689_abnormal_spleen_morphology | 2.15954125 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.07117536 |
| 28 | * MP0002722_abnormal_immune_system | 2.04644885 |
| 29 | MP0005058_abnormal_lysosome_morphology | 2.04218958 |
| 30 | MP0003172_abnormal_lysosome_physiology | 1.99865764 |
| 31 | MP0004808_abnormal_hematopoietic_stem | 1.97503775 |
| 32 | MP0001545_abnormal_hematopoietic_system | 1.93957687 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.93957687 |
| 34 | * MP0002429_abnormal_blood_cell | 1.92635829 |
| 35 | MP0001873_stomach_inflammation | 1.92447863 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.92045922 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.85911133 |
| 38 | MP0009278_abnormal_bone_marrow | 1.85649051 |
| 39 | MP0003724_increased_susceptibility_to | 1.84347003 |
| 40 | MP0001853_heart_inflammation | 1.80122234 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.79868751 |
| 42 | MP0004947_skin_inflammation | 1.79604558 |
| 43 | MP0002006_tumorigenesis | 1.79232476 |
| 44 | MP0005174_abnormal_tail_pigmentation | 1.78912129 |
| 45 | * MP0000703_abnormal_thymus_morphology | 1.72049460 |
| 46 | MP0004510_myositis | 1.60427831 |
| 47 | MP0000490_abnormal_crypts_of | 1.51254163 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.49522198 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.48582511 |
| 50 | MP0003866_abnormal_defecation | 1.47378369 |
| 51 | MP0005451_abnormal_body_composition | 1.46496702 |
| 52 | MP0003690_abnormal_glial_cell | 1.40601919 |
| 53 | MP0008469_abnormal_protein_level | 1.40103758 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.34442445 |
| 55 | MP0002933_joint_inflammation | 1.33334948 |
| 56 | MP0010307_abnormal_tumor_latency | 1.33186714 |
| 57 | MP0002254_reproductive_system_inflammat | 1.27123968 |
| 58 | MP0000858_altered_metastatic_potential | 1.26714202 |
| 59 | MP0005310_abnormal_salivary_gland | 1.23829703 |
| 60 | * MP0003300_gastrointestinal_ulcer | 1.21212967 |
| 61 | MP0008260_abnormal_autophagy | 1.21107246 |
| 62 | MP0005075_abnormal_melanosome_morpholog | 1.18570512 |
| 63 | MP0003448_altered_tumor_morphology | 1.18413768 |
| 64 | MP0000015_abnormal_ear_pigmentation | 1.17642806 |
| 65 | MP0000569_abnormal_digit_pigmentation | 1.17180303 |
| 66 | MP0010094_abnormal_chromosome_stability | 1.14676648 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 1.13455033 |
| 68 | MP0004883_abnormal_blood_vessel | 1.13428657 |
| 69 | MP0008057_abnormal_DNA_replication | 1.12497647 |
| 70 | MP0009840_abnormal_foam_cell | 1.10974269 |
| 71 | MP0002019_abnormal_tumor_incidence | 1.08370744 |
| 72 | MP0001851_eye_inflammation | 1.08226005 |
| 73 | MP0003806_abnormal_nucleotide_metabolis | 1.06073729 |
| 74 | MP0003077_abnormal_cell_cycle | 1.02617655 |
| 75 | MP0000343_altered_response_to | 1.00877216 |
| 76 | MP0008004_abnormal_stomach_pH | 0.97754832 |
| 77 | MP0010352_gastrointestinal_tract_polyps | 0.96141853 |
| 78 | MP0005164_abnormal_response_to | 0.94265909 |
| 79 | MP0005167_abnormal_blood-brain_barrier | 0.93116589 |
| 80 | MP0002095_abnormal_skin_pigmentation | 0.92308285 |
| 81 | MP0008007_abnormal_cellular_replicative | 0.88850528 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.88204659 |
| 83 | MP0002998_abnormal_bone_remodeling | 0.85250014 |
| 84 | MP0002138_abnormal_hepatobiliary_system | 0.83562397 |
| 85 | MP0003111_abnormal_nucleus_morphology | 0.82916187 |
| 86 | MP0004381_abnormal_hair_follicle | 0.82409438 |
| 87 | MP0009764_decreased_sensitivity_to | 0.82043403 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.80886563 |
| 89 | MP0009763_increased_sensitivity_to | 0.77764078 |
| 90 | MP0003075_altered_response_to | 0.76955654 |
| 91 | MP0005076_abnormal_cell_differentiation | 0.76116119 |
| 92 | MP0000313_abnormal_cell_death | 0.74853467 |
| 93 | MP0002332_abnormal_exercise_endurance | 0.73644688 |
| 94 | MP0005166_decreased_susceptibility_to | 0.72422744 |
| 95 | MP0001663_abnormal_digestive_system | 0.70360338 |
| 96 | MP0002139_abnormal_hepatobiliary_system | 0.70085032 |
| 97 | MP0008058_abnormal_DNA_repair | 0.69926644 |
| 98 | MP0000371_diluted_coat_color | 0.68627405 |
| 99 | MP0002132_abnormal_respiratory_system | 0.67162729 |
| 100 | MP0000604_amyloidosis | 0.66961479 |
| 101 | MP0003453_abnormal_keratinocyte_physiol | 0.66743992 |
| 102 | MP0003566_abnormal_cell_adhesion | 0.66661480 |
| 103 | MP0003828_pulmonary_edema | 0.65086251 |
| 104 | MP0008874_decreased_physiological_sensi | 0.62475385 |
| 105 | MP0002693_abnormal_pancreas_physiology | 0.60787921 |
| 106 | * MP0003693_abnormal_embryo_hatching | 0.60387719 |
| 107 | MP0008873_increased_physiological_sensi | 0.59862968 |
| 108 | MP0000249_abnormal_blood_vessel | 0.59151536 |
| 109 | MP0000920_abnormal_myelination | 0.58374419 |
| 110 | MP0005390_skeleton_phenotype | 0.56781588 |
| 111 | MP0006054_spinal_hemorrhage | 0.56729742 |
| 112 | MP0003795_abnormal_bone_structure | 0.56672538 |
| 113 | MP0004957_abnormal_blastocyst_morpholog | 0.56639685 |
| 114 | MP0003329_amyloid_beta_deposits | 0.56266762 |
| 115 | MP0005381_digestive/alimentary_phenotyp | 0.54174962 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.53679826 |
| 117 | MP0003221_abnormal_cardiomyocyte_apopto | 0.53226045 |
| 118 | MP0000598_abnormal_liver_morphology | 0.52649717 |
| 119 | MP0000609_abnormal_liver_physiology | 0.51243644 |
| 120 | MP0001986_abnormal_taste_sensitivity | 0.50866967 |
| 121 | MP0000350_abnormal_cell_proliferation | 0.50677191 |
| 122 | MP0002928_abnormal_bile_duct | 0.49690725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.66836075 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.07944129 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.05807301 |
| 4 | Recurrent viral infections (HP:0004429) | 4.37626023 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.36997480 |
| 6 | Chronic otitis media (HP:0000389) | 4.35506444 |
| 7 | IgM deficiency (HP:0002850) | 4.26304036 |
| 8 | Recurrent fungal infections (HP:0002841) | 4.25908402 |
| 9 | Myositis (HP:0100614) | 4.12578205 |
| 10 | Recurrent bronchitis (HP:0002837) | 3.74691536 |
| 11 | Cellulitis (HP:0100658) | 3.73113335 |
| 12 | Thrombocytosis (HP:0001894) | 3.60097745 |
| 13 | Meningitis (HP:0001287) | 3.58995721 |
| 14 | Recurrent skin infections (HP:0001581) | 3.57594028 |
| 15 | Panhypogammaglobulinemia (HP:0003139) | 3.54434685 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.53800218 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 3.53415053 |
| 18 | T lymphocytopenia (HP:0005403) | 3.49932584 |
| 19 | Abnormality of macrophages (HP:0004311) | 3.45962413 |
| 20 | Chronic obstructive pulmonary disease (HP:0006510) | 3.45187773 |
| 21 | Obstructive lung disease (HP:0006536) | 3.45187773 |
| 22 | Keratoconjunctivitis sicca (HP:0001097) | 3.41768181 |
| 23 | Keratoconjunctivitis (HP:0001096) | 3.41744828 |
| 24 | Inflammation of the large intestine (HP:0002037) | 3.39882789 |
| 25 | Abnormality of T cell number (HP:0011839) | 3.36509487 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.35012838 |
| 27 | Gastrointestinal inflammation (HP:0004386) | 3.33512621 |
| 28 | Agammaglobulinemia (HP:0004432) | 3.26417107 |
| 29 | Gastrointestinal infarctions (HP:0005244) | 3.24729585 |
| 30 | Colitis (HP:0002583) | 3.23735156 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.23057476 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.23057476 |
| 33 | Abnormality of T cells (HP:0002843) | 3.21961798 |
| 34 | Nasal polyposis (HP:0100582) | 3.16653526 |
| 35 | Stomatitis (HP:0010280) | 3.09668358 |
| 36 | Vasculitis (HP:0002633) | 3.08507083 |
| 37 | Thyroiditis (HP:0100646) | 3.08411706 |
| 38 | Increased IgM level (HP:0003496) | 3.00873343 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 2.98458551 |
| 40 | B lymphocytopenia (HP:0010976) | 2.98326086 |
| 41 | Abnormality of B cell number (HP:0010975) | 2.98326086 |
| 42 | Petechiae (HP:0000967) | 2.97620382 |
| 43 | Vacuolated lymphocytes (HP:0001922) | 2.97016448 |
| 44 | Orchitis (HP:0100796) | 2.90975281 |
| 45 | Pustule (HP:0200039) | 2.88878876 |
| 46 | Abnormality of T cell physiology (HP:0011840) | 2.84597914 |
| 47 | Increased cerebral lipofuscin (HP:0011813) | 2.82869113 |
| 48 | Abnormality of the nasal mucosa (HP:0000433) | 2.82178463 |
| 49 | Lymphopenia (HP:0001888) | 2.81764937 |
| 50 | Prolonged bleeding time (HP:0003010) | 2.80746808 |
| 51 | Spontaneous hematomas (HP:0007420) | 2.78371518 |
| 52 | Optic neuritis (HP:0100653) | 2.78295739 |
| 53 | Retrobulbar optic neuritis (HP:0100654) | 2.78295739 |
| 54 | Leukocytosis (HP:0001974) | 2.78074294 |
| 55 | Eosinophilia (HP:0001880) | 2.77336525 |
| 56 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.75348234 |
| 57 | Osteomyelitis (HP:0002754) | 2.70879215 |
| 58 | Gingivitis (HP:0000230) | 2.65095736 |
| 59 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.60721863 |
| 60 | Gastrointestinal stroma tumor (HP:0100723) | 2.59919615 |
| 61 | IgG deficiency (HP:0004315) | 2.59858510 |
| 62 | Granulocytopenia (HP:0001913) | 2.57857229 |
| 63 | Abnormality of the fingertips (HP:0001211) | 2.57696383 |
| 64 | Periodontitis (HP:0000704) | 2.56737886 |
| 65 | Interstitial pulmonary disease (HP:0006530) | 2.55430473 |
| 66 | Severe combined immunodeficiency (HP:0004430) | 2.53939437 |
| 67 | Abnormality of eosinophils (HP:0001879) | 2.52759719 |
| 68 | Abnormal platelet function (HP:0011869) | 2.48348388 |
| 69 | Impaired platelet aggregation (HP:0003540) | 2.48348388 |
| 70 | Epistaxis (HP:0000421) | 2.47689549 |
| 71 | Combined immunodeficiency (HP:0005387) | 2.47390558 |
| 72 | Episodic fever (HP:0001954) | 2.41382235 |
| 73 | Autoimmune hemolytic anemia (HP:0001890) | 2.41357442 |
| 74 | Anorexia (HP:0002039) | 2.41132515 |
| 75 | Arterial thrombosis (HP:0004420) | 2.41003645 |
| 76 | Chronic diarrhea (HP:0002028) | 2.39277494 |
| 77 | Increased serum ferritin (HP:0003281) | 2.38934970 |
| 78 | Verrucae (HP:0200043) | 2.38537206 |
| 79 | Papilloma (HP:0012740) | 2.38537206 |
| 80 | Chronic sinusitis (HP:0011109) | 2.37398486 |
| 81 | Pulmonary embolism (HP:0002204) | 2.37085780 |
| 82 | Pulmonary infiltrates (HP:0002113) | 2.36537449 |
| 83 | Systemic lupus erythematosus (HP:0002725) | 2.35792833 |
| 84 | Hypergammaglobulinemia (HP:0010702) | 2.35649287 |
| 85 | Dysostosis multiplex (HP:0000943) | 2.34290411 |
| 86 | Recurrent sinusitis (HP:0011108) | 2.34064364 |
| 87 | Lymphoma (HP:0002665) | 2.33712982 |
| 88 | Increased IgE level (HP:0003212) | 2.33274714 |
| 89 | Gangrene (HP:0100758) | 2.32823680 |
| 90 | Encephalitis (HP:0002383) | 2.32493786 |
| 91 | Hematochezia (HP:0002573) | 2.30683949 |
| 92 | Abnormality of the prostate (HP:0008775) | 2.29098688 |
| 93 | Purpura (HP:0000979) | 2.27300736 |
| 94 | Hemoptysis (HP:0002105) | 2.25698170 |
| 95 | Agnosia (HP:0010524) | 2.25612688 |
| 96 | Abnormality of the pleura (HP:0002103) | 2.25371756 |
| 97 | Amyloidosis (HP:0011034) | 2.25084201 |
| 98 | Abnormality of glycolipid metabolism (HP:0010969) | 2.24531984 |
| 99 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.24531984 |
| 100 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.24531984 |
| 101 | Chest pain (HP:0100749) | 2.24068111 |
| 102 | Recurrent pneumonia (HP:0006532) | 2.23552168 |
| 103 | Gingival bleeding (HP:0000225) | 2.22997507 |
| 104 | Mutism (HP:0002300) | 2.20315956 |
| 105 | IgA deficiency (HP:0002720) | 2.19911310 |
| 106 | Hypochromic anemia (HP:0001931) | 2.16681311 |
| 107 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.16075338 |
| 108 | Emphysema (HP:0002097) | 2.15164178 |
| 109 | Polyneuropathy (HP:0001271) | 2.13422489 |
| 110 | Loss of speech (HP:0002371) | 2.13068114 |
| 111 | Urticaria (HP:0001025) | 2.10630271 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 2.10020228 |
| 113 | Recurrent lower respiratory tract infections (HP:0002783) | 2.09777373 |
| 114 | Skin ulcer (HP:0200042) | 2.08667598 |
| 115 | Sepsis (HP:0100806) | 2.08185125 |
| 116 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.08172748 |
| 117 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.08172748 |
| 118 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.08172748 |
| 119 | Disinhibition (HP:0000734) | 2.07468398 |
| 120 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.05727183 |
| 121 | Hepatosplenomegaly (HP:0001433) | 2.04276958 |
| 122 | Thoracic kyphosis (HP:0002942) | 2.03376558 |
| 123 | Restrictive lung disease (HP:0002091) | 2.01331633 |
| 124 | Vertigo (HP:0002321) | 1.98311056 |
| 125 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.98216328 |
| 126 | Glomerulopathy (HP:0100820) | 1.94351699 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.99461791 |
| 2 | KIT | 2.77125017 |
| 3 | BLK | 2.67334652 |
| 4 | TYK2 | 2.58894728 |
| 5 | TXK | 2.58768491 |
| 6 | EEF2K | 2.45025581 |
| 7 | CSF1R | 2.38324534 |
| 8 | ZAP70 | 2.35249089 |
| 9 | TBK1 | 2.33343924 |
| 10 | IRAK4 | 2.30392779 |
| 11 | BTK | 2.25766805 |
| 12 | JAK3 | 2.23825514 |
| 13 | PRPF4B | 2.21265582 |
| 14 | STK10 | 2.04336198 |
| 15 | SYK | 2.01162341 |
| 16 | TEC | 2.00000880 |
| 17 | IKBKE | 1.95620088 |
| 18 | MAP3K14 | 1.93877111 |
| 19 | ITK | 1.85803055 |
| 20 | TGFBR2 | 1.80465871 |
| 21 | FES | 1.75943362 |
| 22 | GRK6 | 1.75732837 |
| 23 | MAP3K10 | 1.73891887 |
| 24 | RIPK4 | 1.73437138 |
| 25 | ERN1 | 1.67770793 |
| 26 | PKN2 | 1.65743803 |
| 27 | HCK | 1.58505469 |
| 28 | MAP2K3 | 1.58364836 |
| 29 | JAK1 | 1.51935331 |
| 30 | NME2 | 1.48281118 |
| 31 | IRAK3 | 1.47599744 |
| 32 | GRK7 | 1.45924297 |
| 33 | * LCK | 1.40443389 |
| 34 | CLK1 | 1.40206212 |
| 35 | IKBKB | 1.39171598 |
| 36 | CSK | 1.37370399 |
| 37 | LRRK2 | 1.34831569 |
| 38 | FLT3 | 1.33598847 |
| 39 | TAOK3 | 1.32966413 |
| 40 | TAOK2 | 1.29179087 |
| 41 | BMPR2 | 1.28653236 |
| 42 | LYN | 1.27693637 |
| 43 | PIM1 | 1.11207938 |
| 44 | TRIB3 | 1.11207370 |
| 45 | RPS6KA4 | 1.08308824 |
| 46 | MAP3K13 | 1.07599688 |
| 47 | MAP3K1 | 1.06596004 |
| 48 | SIK2 | 1.01323744 |
| 49 | FGFR4 | 1.01203840 |
| 50 | NEK2 | 0.98733344 |
| 51 | SIK3 | 0.98646754 |
| 52 | EPHB1 | 0.96768708 |
| 53 | IRAK1 | 0.93794924 |
| 54 | FGFR3 | 0.92830647 |
| 55 | PIM2 | 0.91612957 |
| 56 | CDC42BPA | 0.86524843 |
| 57 | SCYL2 | 0.86154964 |
| 58 | CAMKK2 | 0.84403063 |
| 59 | JAK2 | 0.83082721 |
| 60 | MATK | 0.81961356 |
| 61 | STK4 | 0.81551168 |
| 62 | CDK4 | 0.80625395 |
| 63 | CAMKK1 | 0.77156416 |
| 64 | TESK2 | 0.74807276 |
| 65 | IRAK2 | 0.73378394 |
| 66 | MARK3 | 0.72125649 |
| 67 | CHUK | 0.71048450 |
| 68 | RPS6KB2 | 0.69491216 |
| 69 | NLK | 0.68525778 |
| 70 | KSR2 | 0.68421549 |
| 71 | KDR | 0.66773283 |
| 72 | MARK2 | 0.65355512 |
| 73 | CDK12 | 0.65046464 |
| 74 | MAP3K11 | 0.64414948 |
| 75 | YES1 | 0.61597198 |
| 76 | TGFBR1 | 0.60817945 |
| 77 | TRPM7 | 0.60666931 |
| 78 | PTK6 | 0.59791186 |
| 79 | MAPK7 | 0.58718215 |
| 80 | MAP3K5 | 0.57920726 |
| 81 | MAP3K8 | 0.57543686 |
| 82 | MAPK12 | 0.57515490 |
| 83 | PASK | 0.57254748 |
| 84 | CDC7 | 0.56212592 |
| 85 | PAK4 | 0.55460803 |
| 86 | MOS | 0.54553096 |
| 87 | PDPK1 | 0.53911840 |
| 88 | MAPK4 | 0.53696662 |
| 89 | MST4 | 0.52787202 |
| 90 | CDK6 | 0.52530096 |
| 91 | MAP2K6 | 0.52250712 |
| 92 | ADRBK2 | 0.51890148 |
| 93 | TNK2 | 0.51379071 |
| 94 | FYN | 0.51292902 |
| 95 | ATR | 0.50479838 |
| 96 | PRKCQ | 0.50098511 |
| 97 | RPS6KA6 | 0.48854713 |
| 98 | MAPKAPK3 | 0.48125874 |
| 99 | MAP3K3 | 0.46444203 |
| 100 | ALK | 0.46411323 |
| 101 | MAPKAPK2 | 0.45786917 |
| 102 | NEK9 | 0.45408119 |
| 103 | TSSK6 | 0.43650208 |
| 104 | HIPK2 | 0.42231483 |
| 105 | MAPK11 | 0.41523870 |
| 106 | TAOK1 | 0.41413637 |
| 107 | TTN | 0.40562104 |
| 108 | PRKD2 | 0.40316223 |
| 109 | PDK1 | 0.40228461 |
| 110 | CAMK1D | 0.40006041 |
| 111 | CDK9 | 0.38359032 |
| 112 | VRK1 | 0.37654577 |
| 113 | EGFR | 0.37134176 |
| 114 | PIK3CG | 0.36846457 |
| 115 | EIF2AK3 | 0.36605266 |
| 116 | RPS6KL1 | 0.36231512 |
| 117 | RPS6KC1 | 0.36231512 |
| 118 | FGR | 0.32200569 |
| 119 | EIF2AK1 | 0.32142027 |
| 120 | STK16 | 0.31676283 |
| 121 | MAP3K7 | 0.31352261 |
| 122 | PRKCD | 0.30695397 |
| 123 | DAPK2 | 0.29349441 |
| 124 | PRKCH | 0.29300352 |
| 125 | * ABL1 | 0.29157491 |
| 126 | ACVR1B | 0.27148725 |
| 127 | EPHA3 | 0.26775649 |
| 128 | MAP2K2 | 0.26506466 |
| 129 | SMG1 | 0.26252290 |
| 130 | STK11 | 0.25635379 |
| 131 | SGK3 | 0.25084652 |
| 132 | DYRK1B | 0.23679253 |
| 133 | MAP3K6 | 0.23381069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.62430464 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.79423428 |
| 3 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.65642329 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.44731635 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.42181573 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.42028363 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.24217207 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.13558542 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 2.11295402 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.03881092 |
| 11 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.02127592 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.99153803 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.87397182 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.86723903 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 1.85768359 |
| 16 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.76142319 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.76042370 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.75776232 |
| 19 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.74271729 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.73224489 |
| 21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.67033359 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.55590131 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.52661911 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.51771525 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.51104403 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.48619002 |
| 27 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.48441681 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.47347431 |
| 29 | Base excision repair_Homo sapiens_hsa03410 | 1.45300389 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44431613 |
| 31 | Allograft rejection_Homo sapiens_hsa05330 | 1.42385320 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.41116858 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.39812215 |
| 34 | Ribosome_Homo sapiens_hsa03010 | 1.37210213 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.35813894 |
| 36 | Mismatch repair_Homo sapiens_hsa03430 | 1.34804936 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.33147820 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.32249007 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.31290104 |
| 40 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.27541728 |
| 41 | Lysosome_Homo sapiens_hsa04142 | 1.26457584 |
| 42 | Malaria_Homo sapiens_hsa05144 | 1.24762095 |
| 43 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.21132747 |
| 44 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20617682 |
| 45 | Asthma_Homo sapiens_hsa05310 | 1.17967270 |
| 46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16596754 |
| 47 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11193220 |
| 48 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08889344 |
| 49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.07666253 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07091135 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 1.06158755 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01231174 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.99191083 |
| 54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.97795757 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96439163 |
| 56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93903449 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93338202 |
| 58 | Homologous recombination_Homo sapiens_hsa03440 | 0.93251021 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.90378751 |
| 60 | Spliceosome_Homo sapiens_hsa03040 | 0.90004682 |
| 61 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.89848107 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.83839364 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82289407 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.80930419 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.78113878 |
| 66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77885744 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77675423 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77203794 |
| 69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.72684333 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68520139 |
| 71 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68126378 |
| 72 | Phagosome_Homo sapiens_hsa04145 | 0.66454341 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.64835616 |
| 74 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.61475727 |
| 75 | Colorectal cancer_Homo sapiens_hsa05210 | 0.61291305 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60395195 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.59962835 |
| 78 | Cell cycle_Homo sapiens_hsa04110 | 0.59868924 |
| 79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58836015 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57986818 |
| 81 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.57363736 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.54944107 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49909213 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49509775 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49228425 |
| 86 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.46398767 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.45350325 |
| 88 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.45078366 |
| 89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.45026389 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44862052 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44567024 |
| 92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44086049 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.43779620 |
| 94 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.43560832 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42635487 |
| 96 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.42608244 |
| 97 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42475840 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42018142 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.41378935 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.38951313 |
| 101 | Bladder cancer_Homo sapiens_hsa05219 | 0.38460764 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38321721 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38054574 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37641132 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36715937 |
| 106 | RNA transport_Homo sapiens_hsa03013 | 0.34192206 |
| 107 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32818182 |
| 108 | RNA degradation_Homo sapiens_hsa03018 | 0.32682947 |
| 109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32296817 |
| 110 | Sulfur relay system_Homo sapiens_hsa04122 | 0.30586287 |
| 111 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30403899 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30241841 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29487625 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.29317359 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28091166 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.27551790 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26136057 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23496930 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.22334814 |
| 120 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.21089440 |
| 121 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.17742189 |
| 122 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.16910413 |
| 123 | Prostate cancer_Homo sapiens_hsa05215 | 0.16496418 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.15985754 |

